Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.

Hovig, E; Maelandsmo, G; Mellingsaeter, T; Fodstad, O; Mielewczyk, S S; Wolfe, J; Goodchild, J

Hovig, E; Maelandsmo, G; Mellingsaeter, T; Fodstad, O; Mielewczyk, S S; Wolfe, J; Goodchild, J.

Affiliation

Hovig E; The Norwegian Radium Hospital, Oslo.

Antisense Nucleic Acid Drug Dev ; 11(2): 67-75, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11334142

Subject(s)

Neoplasm Proteins/biosynthesis; RNA, Catalytic/metabolism; RNA, Messenger/metabolism; RNA, Neoplasm/metabolism; S100 Proteins/biosynthesis; Antineoplastic Agents/metabolism; Drug Design; Kinetics; Neoplasm Proteins/genetics; S100 Proteins/genetics; Substrate Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / RNA, Neoplasm / S100 Proteins / RNA, Catalytic / Neoplasm Proteins Type of study: Prognostic_studies Language: En Journal: Antisense Nucleic Acid Drug Dev Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA / FARMACOLOGIA Year: 2001 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links